Search Results - "MARLIND, Jessica"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Design, construction, and characterization of a large synthetic human antibody phage display library by Silacci, Michela, Brack, Simon, Schirru, Giulia, Mårlind, Jessica, Ettorre, Anna, Merlo, Adrian, Viti, Francesca, Neri, Dario

    Published in Proteomics (Weinheim) (01-06-2005)
    “…Advances in proteomic research allow the identification of several hundred protein components in complex biological specimens. Structural information is…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Pandemic vaccines: a formidable challenge for pharmacovigilance by Kiazand, Alexandre, Luther, Ruth, Mårlind Würtele, Jessica, Southall, Noel, Domalik, Douglas, Ysander, Magnus

    Published in Nature reviews. Drug discovery (01-01-2023)
    “…The COVID-19 vaccine effort was the most rapid global response to a health crisis in history. The challenge of managing unparalleled volumes of safety…”
    Get full text
    Journal Article
  3. 3

    Antibody-Mediated Delivery of Interleukin-2 to the Stroma of Breast Cancer Strongly Enhances the Potency of Chemotherapy by MARLIND, Jessica, KASPAR, Manuela, TRACHSEL, Eveline, SOMMAVILLA, Roberto, HINDLE, Stuart, BACCI, Camilla, GIOVANNONI, Leonardo, NERI, Dario

    Published in Clinical cancer research (15-10-2008)
    “…Purpose: There is an interest in the discovery of biopharmaceuticals, which are well tolerated and which potentiate the action of anthracyclines and taxanes in…”
    Get full text
    Journal Article
  4. 4

    In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives by Ahlskog, Julia K.J., Dumelin, Christoph E., Trüssel, Sabrina, Mårlind, Jessica, Neri, Dario

    Published in Bioorganic & medicinal chemistry letters (15-08-2009)
    “…We describe the synthesis and characterization of two acetazolamide derivatives containing either a charged fluorophore or an albumin-binding moiety, which…”
    Get full text
    Journal Article
  5. 5

    The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study by Beer, Karsten, Müller, Martin, Hew-Winzeler, Anna Marie, Bont, Adriano, Maire, Philippe, You, Xiaojun, Foulds, Pamela, Mårlind, Jessica, Curtius, Daniela

    Published in BMC neurology (10-11-2011)
    “…Interferon beta (IFNβ) and glatiramer acetate (GA) are administered by subcutaneous (SC) or intramuscular (IM) injection. Patients with multiple sclerosis (MS)…”
    Get full text
    Journal Article